Clinical Trial Update: Human Albumin for Resuscitation in Surgical Septic Shock: A Randomized Controlled Trial (ALBUS Study) [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating human albumin for resuscitation in surgical septic shock, sponsored by Mahidol University; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Human Albumin

Snippet

Sponsor: Mahidol University | Conditions: Critical Illness, Septic Shock | Phase 3 | Status: NOT_YET_RECRUITING